Cargando…

APOC1 promotes the progression of osteosarcoma by binding to MTCH2

Osteosarcoma is the most prevalent primary malignant bone cancer worldwide. Apolipoprotein C1 (APOC1) and mitochondrial carrier homolog 2 (MTCH2) have been identified to be upregulated during the oncogenesis and metastasis of osteosarcoma. The aim of the present study was to explore the role of APOC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Renjie, He, Huixian, He, Xinxin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2023
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996334/ https://www.ncbi.nlm.nih.gov/pubmed/36911382 http://dx.doi.org/10.3892/etm.2023.11862

Ejemplares similares

Insertases Scramble Lipids: Molecular Simulations of MTCH2
por: Bartoš, Ladislav, et al.
Publicado: (2023)

MTCH2 is a mitochondrial outer membrane protein insertase
por: Guna, Alina, et al.
Publicado: (2022)

Apolipoprotein C1 (APOC1) promotes tumor progression via MAPK signaling pathways in colorectal cancer
por: Ren, Hui, et al.
Publicado: (2019)

MARCH5 requires MTCH2 to coordinate proteasomal turnover of the MCL1:NOXA complex
por: Djajawi, Tirta Mario, et al.
Publicado: (2020)

The modified mitochondrial outer membrane carrier MTCH2 links mitochondrial fusion to lipogenesis
por: Labbé, Katherine, et al.
Publicado: (2021)

MTCH2-mediated mitochondrial fusion drives exit from naïve pluripotency in embryonic stem cells
por: Bahat, Amir, et al.
Publicado: (2018)

Mimp/Mtch2, an Obesity Susceptibility Gene, Induces Alteration of Fatty Acid Metabolism in Transgenic Mice
por: Bar-Lev, Yamit, et al.
Publicado: (2016)

Upregulation Mitochondrial Carrier 1 (MTCH1) Is Associated with Cell Proliferation, Invasion, and Migration of Liver Hepatocellular Carcinoma
por: Chen, Guolin, et al.
Publicado: (2021)

Inhibition of mitochondrial carrier homolog 2 (MTCH2) suppresses tumor invasion and enhances sensitivity to temozolomide in malignant glioma
por: Yuan, Qiuyun, et al.
Publicado: (2021)

Upregulation of APOC1 Promotes Colorectal Cancer Progression and Serves as a Potential Therapeutic Target Based on Bioinformatics Analysis
por: Tang, Weiwei, et al.
Publicado: (2023)

Loss of forebrain MTCH2 decreases mitochondria motility and calcium handling and impairs hippocampal-dependent cognitive functions
por: Ruggiero, Antonella, et al.
Publicado: (2017)

40 Years of the APOC Partnership
por: Roungou, Jean-Baptist, et al.
Publicado: (2015)

Stop codon read-through of mammalian MTCH2 leading to an unstable isoform regulates mitochondrial membrane potential
por: Manjunath, Lekha E., et al.
Publicado: (2020)

Associations of the APOC3 rs5128 polymorphism with plasma APOC3 and lipid levels: a meta-analysis
por: Song, Yongyan, et al.
Publicado: (2015)

ApoC3 is expressed in oocytes and increased expression is associated with PCOS progression
por: Zhou, Jiahe, et al.
Publicado: (2023)

AAV-Mediated ApoC2 Gene Therapy: Reversal of Severe Hypertriglyceridemia and Rescue of Neonatal Death in ApoC2-Deficient Hamsters
por: Yang, Chun, et al.
Publicado: (2020)

APOC3: Triglycerides do matter
por: Hassan, Mohamed
Publicado: (2014)

lncRNA APOC1P1-3 promoting anoikis-resistance of breast cancer cells
por: Lu, Qi, et al.
Publicado: (2021)

APOC3 Interference for Familial Chylomicronaemia Syndrome
por: Hegele, Robert A
Publicado: (2022)

Cloning, purification, and characterization of an organic solvent-tolerant chitinase, MtCh509, from Microbulbifer thermotolerans DAU221
por: Lee, Hyo-Jung, et al.
Publicado: (2018)

Serum APOC1 levels are decreased in young autoantibody positive children who rapidly progress to type 1 diabetes
por: Hirvonen, M. Karoliina, et al.
Publicado: (2023)

APOC-III: a Gatekeeper in Controlling Triglyceride Metabolism
por: Giammanco, Antonina, et al.
Publicado: (2023)

Mitochondrial carrier 1 (MTCH1) governs ferroptosis by triggering the FoxO1-GPX4 axis-mediated retrograde signaling in cervical cancer cells
por: Wang, Xuan, et al.
Publicado: (2023)

ENO1 Binds to ApoC3 and Impairs the Proliferation of T Cells via IL-8/STAT3 Pathway in OSCC
por: Wang, Jing, et al.
Publicado: (2022)

Upregulation of ALDH1B1 promotes tumor progression in osteosarcoma
por: Wang, Xin, et al.
Publicado: (2017)

Managing the Fight against Onchocerciasis in Africa: APOC Experience
por: Fobi, Grace, et al.
Publicado: (2015)

Association of an APOC3 promoter variant with type 2 diabetes risk and need for insulin treatment in lean persons
por: van Hoek, M., et al.
Publicado: (2011)

Apoc2 loss-of-function zebrafish mutant as a genetic model of hyperlipidemia
por: Liu, Chao, et al.
Publicado: (2015)

Ethnic differences in ApoC-III concentration and the risk of cardiovascular disease: No evidence for the cardioprotective role of rare/loss of function APOC3 variants in non-Europeans
por: Rout, Madhusmita, et al.
Publicado: (2022)

APOE and APOC1 gene polymorphisms are associated with cognitive impairment progression in Chinese patients with late-onset Alzheimer's disease
por: Zhou, Qin, et al.
Publicado: (2014)

APOC3 induces endothelial dysfunction through TNF-α and JAM-1
por: Tao, Yun, et al.
Publicado: (2016)

Association between APOC1 Polymorphism and Alzheimer’s Disease: A Case-Control Study and Meta-Analysis
por: Zhou, Qin, et al.
Publicado: (2014)

APOE ɛ4 allele and TOMM40‐APOC1 variants jointly contribute to survival to older ages
por: Kulminski, Alexander M., et al.
Publicado: (2022)

Deficient Cholesterol Esterification in Plasma of apoc2 Knockout Zebrafish and Familial Chylomicronemia Patients
por: Liu, Chao, et al.
Publicado: (2017)

APOC1 as a novel diagnostic biomarker for DN based on machine learning algorithms and experiment
por: Yu, Kuipeng, et al.
Publicado: (2023)

Screening and Identification of APOC1 as a Novel Potential Biomarker for Differentiate of Mycoplasma pneumoniae in Children
por: Li, Jieqiong, et al.
Publicado: (2016)

New Therapeutic Approaches to the Treatment of Dyslipidemia 1: ApoC-III and ANGPTL3
por: Kim, Ji Yoon, et al.
Publicado: (2023)

ApoC-III ASO promotes tissue LPL activity in the absence of apoE-mediated TRL clearance
por: Ramms, Bastian, et al.
Publicado: (2019)

Apolipoprotein C1 (APOC1): A Novel Diagnostic and Prognostic Biomarker for Cervical Cancer
por: Shi, Xiu, et al.
Publicado: (2020)

TUFT1 Promotes Osteosarcoma Cell Proliferation and Predicts Poor Prognosis in Osteosarcoma Patients
por: Yu, Yao-Ping, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_46rmukviqii0tph8p90oi8eo7a